
John Matthew Mauro
Examiner (ID: 6494, Phone: (571)272-6070 , Office: P/1625 )
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1622, 1625 |
| Total Applications | 896 |
| Issued Applications | 752 |
| Pending Applications | 0 |
| Abandoned Applications | 151 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17452965
[patent_doc_number] => 11267810
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-08
[patent_title] => Aminopyrimidine compound and composition comprising same and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/641715
[patent_app_country] => US
[patent_app_date] => 2018-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16153
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16641715
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/641715 | Aminopyrimidine compound and composition comprising same and use thereof | Aug 20, 2018 | Issued |
Array
(
[id] => 13929197
[patent_doc_number] => 20190048114
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-14
[patent_title] => NON-HALOGENATED FLAME RETARDANT HINDERED AMINE LIGHT STABILIZER IMPACT MODIFIERS
[patent_app_type] => utility
[patent_app_number] => 16/107135
[patent_app_country] => US
[patent_app_date] => 2018-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11015
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16107135
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/107135 | Non-halogenated flame retardant hindered amine light stabilizer impact modifiers | Aug 20, 2018 | Issued |
Array
(
[id] => 18051595
[patent_doc_number] => 11524966
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-12-13
[patent_title] => Carboxamides as ubiquitin-specific protease inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/637692
[patent_app_country] => US
[patent_app_date] => 2018-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 121246
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 535
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16637692
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/637692 | Carboxamides as ubiquitin-specific protease inhibitors | Aug 8, 2018 | Issued |
Array
(
[id] => 15962989
[patent_doc_number] => 20200165246
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-28
[patent_title] => SUBSTITUTED PENTA-FUSED HEXA-HETEROCYCLIC COMPOUNDS, PREPARATION METHOD THEREFOR, DRUG COMBINATION AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/636333
[patent_app_country] => US
[patent_app_date] => 2018-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45145
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 449
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16636333
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/636333 | Substituted penta-fused hexa-heterocyclic compounds, preparation method therefor, drug combination and use thereof | Aug 2, 2018 | Issued |
Array
(
[id] => 14948231
[patent_doc_number] => 10435373
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-08
[patent_title] => Drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases
[patent_app_type] => utility
[patent_app_number] => 16/054416
[patent_app_country] => US
[patent_app_date] => 2018-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 17
[patent_no_of_words] => 27059
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 306
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16054416
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/054416 | Drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases | Aug 2, 2018 | Issued |
Array
(
[id] => 18172662
[patent_doc_number] => 11572359
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-07
[patent_title] => PARP/PI3K double-target inhibit containing pyridopyrimidine structure
[patent_app_type] => utility
[patent_app_number] => 16/769893
[patent_app_country] => US
[patent_app_date] => 2018-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7355
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16769893
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/769893 | PARP/PI3K double-target inhibit containing pyridopyrimidine structure | Jul 31, 2018 | Issued |
Array
(
[id] => 14213785
[patent_doc_number] => 20190119277
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-25
[patent_title] => VINBLASTINE 20' AMIDES: SYNTHETIC ANALOGS THAT MAINTAIN OR IMPROVE POTENCY AND SIMULTANEOUSLY OVERCOME Pgp-DERIVED EFFLUX AND RESISTANCE
[patent_app_type] => utility
[patent_app_number] => 16/052307
[patent_app_country] => US
[patent_app_date] => 2018-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44628
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 253
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16052307
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/052307 | Vinblastine 20'' amides: synthetic analogs that maintain or improve potency and simultaneously overcome Pgp-derived efflux and resistance | Jul 31, 2018 | Issued |
Array
(
[id] => 16012467
[patent_doc_number] => 20200181076
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => CATECHOL-DERIVATIVE COMPOUNDS AND THEIR USE
[patent_app_type] => utility
[patent_app_number] => 16/636102
[patent_app_country] => US
[patent_app_date] => 2018-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23615
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 568
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16636102
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/636102 | CATECHOL-DERIVATIVE COMPOUNDS AND THEIR USE | Jul 31, 2018 | Abandoned |
Array
(
[id] => 15930957
[patent_doc_number] => 20200157112
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-21
[patent_title] => 1,2-DIHYDRO-3H-PYRAZOLO[3,4-D]PYRIMIDIN-3-ONE ANALOGS
[patent_app_type] => utility
[patent_app_number] => 16/635348
[patent_app_country] => US
[patent_app_date] => 2018-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25182
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -52
[patent_words_short_claim] => 605
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16635348
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/635348 | L,2-dihydro-3H-pyrazolo[3,4-D]pyrimidin-3-one analogs | Jul 30, 2018 | Issued |
Array
(
[id] => 16321239
[patent_doc_number] => 10781195
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-22
[patent_title] => Process to produce 5-hydroxymethylfurfural (HMF) from carbohydrates using a solvent system containing water and a polar aprotic solvent
[patent_app_type] => utility
[patent_app_number] => 16/050522
[patent_app_country] => US
[patent_app_date] => 2018-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 7236
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16050522
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/050522 | Process to produce 5-hydroxymethylfurfural (HMF) from carbohydrates using a solvent system containing water and a polar aprotic solvent | Jul 30, 2018 | Issued |
Array
(
[id] => 16806013
[patent_doc_number] => 20210128566
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => NOVEL FUNCTIONALIZED PURINE-2,6-DIONES AND THEIR USE IN MEDICINE
[patent_app_type] => utility
[patent_app_number] => 16/633260
[patent_app_country] => US
[patent_app_date] => 2018-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21126
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16633260
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/633260 | NOVEL FUNCTIONALIZED PURINE-2,6-DIONES AND THEIR USE IN MEDICINE | Jul 26, 2018 | Abandoned |
Array
(
[id] => 15963027
[patent_doc_number] => 20200165265
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-28
[patent_title] => COMPOUND AS ACC INHIBITOR AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/632633
[patent_app_country] => US
[patent_app_date] => 2018-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22221
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16632633
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/632633 | Compound as ACC inhibitor and use thereof | Jul 24, 2018 | Issued |
Array
(
[id] => 13576893
[patent_doc_number] => 20180339995
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-29
[patent_title] => PHOTOCHROMIC AND ELECTROCHROMIC DIARYLCYCLOPENTENE DERIVATIVES AS OPTICAL FILTERS
[patent_app_type] => utility
[patent_app_number] => 16/045186
[patent_app_country] => US
[patent_app_date] => 2018-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32614
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 415
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16045186
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/045186 | Diarylethene compounds and uses thereof | Jul 24, 2018 | Issued |
Array
(
[id] => 14566821
[patent_doc_number] => 20190211017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-11
[patent_title] => METHOD OF TREATMENT USING SUBSTITUTED PYRAZOLO[1,5-A] PYRIMIDINE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/044653
[patent_app_country] => US
[patent_app_date] => 2018-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20119
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16044653
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/044653 | Method of treatment using substituted pyrazolo[1,5-A] pyrimidine compounds | Jul 24, 2018 | Issued |
Array
(
[id] => 14102147
[patent_doc_number] => 20190092749
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-28
[patent_title] => EPAC1 ACTIVATORS AS HIV LATENCY REVERSAL AGENTS (LRA)
[patent_app_type] => utility
[patent_app_number] => 16/034558
[patent_app_country] => US
[patent_app_date] => 2018-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10134
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 191
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16034558
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/034558 | EPAC1 activators as HIV latency reversal agents (LRA) | Jul 12, 2018 | Issued |
Array
(
[id] => 16756558
[patent_doc_number] => 10975095
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-13
[patent_title] => Bicyclic ketone compounds and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/034207
[patent_app_country] => US
[patent_app_date] => 2018-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 88326
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 329
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16034207
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/034207 | Bicyclic ketone compounds and methods of use thereof | Jul 11, 2018 | Issued |
Array
(
[id] => 16756558
[patent_doc_number] => 10975095
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-13
[patent_title] => Bicyclic ketone compounds and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/034207
[patent_app_country] => US
[patent_app_date] => 2018-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 88326
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 329
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16034207
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/034207 | Bicyclic ketone compounds and methods of use thereof | Jul 11, 2018 | Issued |
Array
(
[id] => 16756558
[patent_doc_number] => 10975095
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-13
[patent_title] => Bicyclic ketone compounds and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/034207
[patent_app_country] => US
[patent_app_date] => 2018-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 88326
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 329
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16034207
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/034207 | Bicyclic ketone compounds and methods of use thereof | Jul 11, 2018 | Issued |
Array
(
[id] => 16756558
[patent_doc_number] => 10975095
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-13
[patent_title] => Bicyclic ketone compounds and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/034207
[patent_app_country] => US
[patent_app_date] => 2018-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 88326
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 329
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16034207
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/034207 | Bicyclic ketone compounds and methods of use thereof | Jul 11, 2018 | Issued |
Array
(
[id] => 15673459
[patent_doc_number] => 10600973
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-24
[patent_title] => Synthetic method of fused heteroaromatic compound and fused heteroaromatic compound, and intermediate thereof
[patent_app_type] => utility
[patent_app_number] => 16/033574
[patent_app_country] => US
[patent_app_date] => 2018-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9538
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16033574
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/033574 | Synthetic method of fused heteroaromatic compound and fused heteroaromatic compound, and intermediate thereof | Jul 11, 2018 | Issued |